The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNIF-a-initiated apoptosis
1998

Lactacystin Induces Apoptosis in Resistant CLL Lymphocytes

Sample size: 25 publication Evidence: moderate

Author Information

Author(s): J Delic, P Masdehors, S Omura, J-M Cosset, J Dumont, J-L Binet, H Magdelenat

Primary Institution: Institut Curie, Paris

Hypothesis

Can the proteasome inhibitor lactacystin sensitize chemo- and radioresistant chronic lymphocytic leukaemia lymphocytes to apoptosis?

Conclusion

Lactacystin can trigger apoptosis in resistant CLL lymphocytes, making them sensitive to TNF-a treatment.

Supporting Evidence

  • Lactacystin induced apoptosis in 55% to 85% of resistant CLL lymphocytes.
  • Normal lymphocytes showed only 7% to 9% apoptosis with lactacystin.
  • Resistant CLL lymphocytes were unable to activate apoptosis upon irradiation.

Takeaway

Lactacystin helps sick blood cells die when they usually don't, which could help treat some cancer patients.

Methodology

Human lymphocytes were isolated from normal and leukaemic donors, treated with lactacystin, irradiated, and assessed for apoptosis using fluorescence microscopy.

Limitations

The study primarily focuses on a specific subset of CLL patients, which may limit generalizability.

Participant Demographics

25 CLL patients, including 2 resistant and 23 sensitive to treatment.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication